Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-28T10:49:10.114Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of a Healthcare-Associated Urinary Tract Infection Combination Antibiogram

Published online by Cambridge University Press:  13 June 2016

Jenna Wick ,
Kirthana Beaulac  and
Shira Doron
Jenna Wick*
Affiliation:
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts
Kirthana Beaulac
Affiliation:
Department of Pharmacy, Tufts Medical Center, Boston, Massachusetts.
Shira Doron
Affiliation:
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts
*
Address correspondence to Jenna Wick, BS, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, 800 Washington St, Box 238, Boston, MA 02111 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

We created a 2013 combination antibiogram of healthcare-associated urinary tract infection. The 2013 antibiogram–determined regimen was evaluated in a 2014 cohort who had received empirical therapy. The regimen was statistically more likely to represent adequate treatment than actual prescriptions. A customized antibiogram may guide empirical therapy for specific patients.

Infect Control Hosp Epidemiol 2016;37:1101–1104

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 9 , September 2016 , pp. 1101 - 1104
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented in part: IDWeek 2015; San Diego, California; October 7–11, 2015 (Abstract XXX).

References

REFERENCES

1. Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data, 4th ed. Wayne, PA: CLSI, 2014:M39–A4.Google Scholar
2. Hebert, C, Ridgway, J, Vekhter, B, Brown, EC, Weber, SG, Robicsek, A. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol 2012;33:381–388.Google Scholar
3. Aguilar-Duran, S, Horcajada, JP, Sorlí, L, et al. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections. J Infect 2012;64:478–483.Google Scholar
4. Esparcia, A, Artero, A, Eiros, JM, et al. Influence of inadequate antimicrobial therapy on prognosis in elderly patients with severe urinary tract infections. Eur J Intern Med 2014;25:523–527.Google Scholar
5. Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–e120.Google Scholar
6. Gordon, KA, Jones, RN, SENTRY Participant Groups (Europe, Latin America, North America). Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 2003;45:295–301.Google Scholar
7. Bouchillon, SK, Badal, RE, Hoban, DJ, Hawser, SP. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009−2011. Clin Ther 2013;35:872–877.Google Scholar